T Cell Immunobiology of Alloimmune Thrombocytopenias

Archivum Immunologiae et Therapiae Experimentalis

Volumn 46, Issue 5, 1998, Pages 269-275

  Gorski, Jack ^a   Yassai, Maryam ^a   Wu, Shenhong ^a,b   Maślanka, Krystyna ^a,c  

^a BLOOD RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE   (Poland)

Author keywords

Alloantibodies; MHC restriction; Peptide binding

Indexed keywords

ALLOANTIGEN; FIBRINOGEN RECEPTOR;

ANIMAL; BLOOD; GENETIC POLYMORPHISM; GENETICS; HUMAN; IMMUNOLOGY; REVIEW; T LYMPHOCYTE; THROMBOCYTE; THROMBOCYTOPENIA;

ANIMALS; BLOOD PLATELETS; HUMANS; ISOANTIGENS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; POLYMORPHISM, GENETIC; T-LYMPHOCYTES; THROMBOCYTOPENIA;

EID: 0032238769     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. BOWDITCH R. D., TANI P. H., HALLORAN C. E , FRELINGER A. L. III, McMiLLAN R. and GINSBERG M. H. (1992): Localization of a PIA1 epitope to the amino terminal 66 residues of platelet glycoprotein IIIa. Blood, 79, 559-562.
2. BRUNNER-BOLLIGER S., KIEFEL V., HORBER F. F., NYDEGGER U. E. and BERCHTOLD P. (1997): Antibody studies in a patient with acute thrombocytopenia following infusion of plasma containing anti-PI(A1). Am. J. Hematol., 56, 119 - 121.
3. CHEN B. P., MADRIGAL A. and PARHAM P. (1990): Cytotoxic T cell recognition of an endogenous class I HLA peptide presented by a class II HLA molecule. J. Exp. Med., 172, 779 - 788.
4. ECKELS D. D. (1990): Alloreactivity: allogeneic presentation of endogenous peptide or direct recognition of MHC polymorphism? A review. Tissue Antigens, 35, 49 - 55.
5. A and Bak alloantigenic epitopes. Blood, 78, 681 - 687.
6. GORSKI J., YASSAI M., ZHU X., KISSELLA B., KEEVER C. and FLOMENBERG N. (1994): Circulating T cell repertoire complexity in normal individuals and bone marrow recipients analyzed by CDR3 size spectratyping. Correlation with immune status. J. Immunol., 152, 5109 - 5119.
7. 3. Blood, 86, 234 - 242.
8. JOYCE S. and NATHENSON S. G. (1996): Alloreactivity, antigen recognition and T-cell selection: three diverse T-cell recognition problems with a common solution. Immunol. Rev., 154, 59 - 103.
9. A2). Hum. Immunol., 34, 253-256.
10. L'ABBE D., TREMBLAY L., FILION M., BUSQUE L., GOLDMAN M., DECARY F. and CHARTRAND P. (1992): Alloimmunization to platelet antigen HPA-1a (PIA1) is strongly associated with both HLA-DRB3*0101 and HLA-DQB1*0201. Hum. Immunol., 34, 107 - 114
11. LECHLER R. I., LOMBARDI G., BATCHELOR J. R., REINSMOEN N. and BACH F. H. (1990): The molecular basis of alloreactivity. Immunol. Today. 11, 83 - 88.
12. LIU Z., SUN Y. K., Xi Y P., MAFFEI A., REED E., HARRIS P. and SUCIU-FOCA N. (1993): Contribution of direct and indirect recognition pathways to T cell alloreactivity. J. Exp. Med., 177, 1643 - 1650.
13. MARZICH C., STROHM P. L., AYAS M. and COCHRAN R. K. (1996): Neonatal thrombocytopenia caused by passive transfer of anti-PLA1 antibody by blood transfusion. J. Pediatr., 128, 137 - 139.
14. MASLANKA K., LUCAS G. F., GRONOWSKA A., DAVIS J. G. and ZUPANSKA B. (1989): A second case of neonatal alloimmune thrombocytopenia due to fetomaternal anti-PIA2(Zwb, HPA1b) antibodies. Haematologia, 22, 109 - 113.
15. MASIANKA K., PIATEK T., YASSAI M. and GORSKI J. (1995): Molecular analysis of T cell repertoires. Spectratypes generated by multiplex polymerase chain reaction and evaluated by radioactivity or fluorescence. Hum. Immunol., 44, 28 - 34.
16. MASLANKA K., YASSAI M. and GORSKI J. (1996): Molecular identification of T cells that respond in primary bulk culture to a peptide derived from a platelet glycoprotein implicated in neonatal alloimmune thrombocytopenia. J. Clin. Invest., 98, 1802 - 1808.
17. MATZINGER P. (1993): Why positive selection? Immunol. Rev., 135, 81 - 117.
18. MERCIER P., CHICHEPORTICHE C., REVIRON D., DABANIAN C., BOURGUE F., CHIARONI J., DIALLO M. and DELORD Y. (1994): Neonatal thrombocytopenia in HLA-DR-, DQ, -DP-typed mother due to rare anti-HPA-1b (PLA2) (Zwb) fetomaternal immunization. Vox Sang, 67, 46 - 51.
19. MUELLER-EECKHARDT C., BECKER T., WEISHEIT M., WITZ C. and SANTOSO S. (1986): Neonatal alloimmune thrombocytopenia due to fetomaternal Zwb (HPA1b) incompatibility. Vox Sang, 50, 94 - 96.
20. a. Vox Sang, 57, 90 - 91.
21. NEWMAN P. J., MCFARLAND J. G. and ASTER R. H. (1994): Alloimmune thrombocytopenia. In LOSCALZO J. and SCHAFER A. I. (eds.): Thrombosis and hemorrhage. Blackwell Scientific Publications, Boston, 529 - 543.
22. NEWMAN P. J., GORSKI J., WHITE G. C., GIDWITZ S., CRETNEY C. J. and ASTER R. H. (1988): Enzymatic amplification of platelet-specific mRNA using the polymerase chain reaction. J. Clin. Invest., 82, 739 - 743.
23. NEWMAN P. J. and VALENTIN N. (1995): Human platelet alloantigens: recent findings. New perspectives. Thromb. Haematol., 74, 234 - 239.
24. 33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. J. Clin. Invest, 83, 1778 - 1781.
25. PANZER S., AUERBACH L., CECHOVA E., FISCHER G., HOLENSTEINE A., KITL E. M., MAYR W. R., PUTZ M., WAGENBICHLER P. and WALCHSHOFER S. (1995): Maternal alloimmunization against fetal platelet antigens: a prospective study. Br. J. Haematol., 90, 655 - 660.
26. SEMANA G., ZAZOUN T., ALIZADEH M., MOREL-KOOP M. C., GENETET B. and KAPLAN C. (1996): Genetic susceptibility and anti-human platelet antigen 5b alloimmunization role of HLA class II and TAP genes. Hum. Immunol., 46, 114 - 119.
27. SHERMAN L. A. and CHATTOPARDAY S. (1993): The molecular basis of allorecognition. Ann. Rev. Immunol., 11, 385 - 402.
28. VALENTIN N., VISENTIN G. P. and NEWMAN P. J. (1995): Involvement of the cysteine-rich domain of glycoprotein IIIa in the expression of the human platelet alloantigen, PIA1: evidence for heterogeneity in the humoral response Blood, 85, 3028 - 3033.
29. A1 antigen. Hum. Immunol., 27, 73 - 79.
30. Wu S. and GORSKI J. (1996): The MHC class II-associated invariant chain-derived peptide CLIP binds to the peptide binding groove of the class II molecules. Mol. Immunol., 33, 371 - 377.
31. Wu S., MASLANKA K. and GORSKI J. (1997): An integrin polymorphism that defines reactivity with alloantibodies generates an anchor for class II peptide binding. A model for unidirectional alloimmune responses. J. Immunol., 158, 3221 - 3226.
32. YASSAI M., MCFARLAND J. G., NEWTON-NASH D., NEWMAN P. J., ECKELS D. D. and GORSKI J. (1992): T cell receptor and alloimmune thrombocytopenias: a model for autoimmune diseases? Ann. Med. Interne, 143, 365 - 370.
33. YASSAI M., NAUMOVA E and GORSKI J. (1997): Generation of TCR spectratypes by multiplex PCR for T cell repertoire analysis. In OKSENBERG J. R. (ed.): The human antigen T cell receptor. Selected protocols and applications. Landes Bioscience, Austin TX, 326 - 372.